UAB’s ongoing research for countermeasures to bromine or chlorine exposure — from either industrial spills or chemical attack — gets a boost with a new NIH grant.
Four of the most world renowned scholars and influential leaders in the field of infectious disease research will come to UAB to honor the legacy of the late Distinguished Professor Charles Alford, M.D.
Four projects were awarded through the first School of Medicine AMC21 Reload Multi-Investigator Grants, a broad funding opportunity provided through the Academic Enrichment Fund that enables faculty members to organize and integrate multi-disciplinary teams of accomplished investigators to compete successfully for long-term extramural support.
Between-hospital variations in active treatment explain much of the difference seen in infants born at 22 to 24 weeks of gestation.
UAB yields two-plus winners for fourth consecutive year for national undergraduate research scholarship program.
Previous research indicated six weeks of treatment improved hearing, but new findings published in the New England Journal of Medicine reveal six months is better.
Unborn child diagnosed with rare syndrome when mom was five months’ pregnant; parents now prepare for difficult road ahead.
The manufacturer of a new medication for Rett syndrome studied at UAB is encouraged by the drug’s performance.
Two highly acclaimed cancer researchers, Ravi Bhatia, M.D., and Smita Bhatia, M.D., MPH, will join UAB in January 2015.
Smita Bhatia, M.D., MPH, a distinguished pediatric oncologist with a strong interest in cancer outcomes, will be join the School of Medicine to tackle the health challenges cancer survivors face during and after treatment.